News | March 04, 2009

Echo Allows Physicians to Treat Complex Conditions Without Open Heart Surgery

March 4, 2009 - Physicians will be able to move away from pure surgical approaches and utilize less invasive techniques for the treatment of structural heart disease with the help of cardiovascular ultrasound technology, according to a new guideline document in the March issue of the Journal of the American Society of Echocardiography (JASE).

The use of echocardiography, or heart ultrasound, to guide a physician through a procedure as it is being performed has allowed physicians to treat some patients with complex conditions without open heart surgery, and has made the minimally invasive procedures to correct the conditions safer and faster, while improving the overall results for many patients.

Heart Ultrasound has been used for decades to diagnose heart conditions and is highly regarded by physicians world-wide for its ability to produce live, moving images of the heart as it works, for it’s portability, and because it is non-invasive and radiation-free, making it appropriate for use on patients of all age groups. Because echocardiography provides a safe and real-time view of the cardiovascular system, physicians can now use echocardiography to guide minimally invasive procedures in the heart catheterization and arrhythmia laboratories for conditions that once required open heart surgery.

“A major advantage of echocardiography over other advanced imaging is that echocardiography is mobile and real time. Echocardiograms can be recorded at the bedside, in the cardiovascular intensive care unit, in the emergency room—virtually any place that can accommodate a wheeled cart or even a machine the size of a laptop,” said Richard E. Kerber, M.D., a lead author of the article. “This tremendous advantage allows for the performance of imaging immediately before, during, and after various procedures involving interventions.”

The guideline document outlines each type of echocardiography study as it relates to specific procedures, and makes recommendations to help guide the selection of the "right" type of echocardiogram for the procedure being performed. Procedures addressed in the document include: transatrial septal catheterization , using balloons to open tight mitral valves, closing holes in the heart (atrial septal defects)with clamshell devices, guiding the placement of artificial valves to replace degenerated native valves and more.

The ASE Guideline Document, “Echocardiography-Guided Interventions” discusses all modalities of echocardiography, but emphasizes "intracardiac echocardiography" or ICE, which is a newer type of echo that places the imaging probe within the heart during these procedures.

“When working on the heart with these less invasive techniques, imaging the procedure as it is being performed (in real time) with echocardiography has taken on a central role in selecting the right patients to work on, guiding the procedures as they are being performed, and monitoring their safety during the procedure,” said Dr. Frank Silvestry, one of the lead authors of the guideline document. “The use of imaging techniques to guide even well-established procedures enhances the efficiency and safety of these procedures.”

This is the first document of its kind that sets the standard for imaging during procedures, and serves as an important reference to a wide variety of physicians. View the full article at www.asecho.org

The American Society of Echocardiography (ASE) is a professional organization of physicians, cardiac sonographers, nurses and scientists involved in echocardiography, the use of ultrasound to image the heart and cardiovascular system. The organization was founded in 1975 and has more than 15,000 members nationally and internationally.

For more information on ASE, visit www.asecho.org or ASE’s Public Information site, www.SeeMyHeart.org

Related Content

New Guideline Published for Evaluation of Valvular Regurgitation After Catheter-based Valve Interventions
News | Cardiovascular Ultrasound | April 30, 2019
A new document compiled by four cardiac imaging professional societies provides a resource to guide clinicians in best...
Six Predictions on How the Ultrasound Systems Market Will Expand Through 2022
News | Ultrasound Imaging | April 26, 2019
With healthcare costs continuing to rise, affordable and accurate imaging and diagnosis achieved through ultrasound...
Ebit and DiA Imaging Analysis Partner on AI-based Cardiac Ultrasound Analysis
News | Cardiovascular Ultrasound | April 16, 2019
DiA Imaging Analysis has partnered with the Italian healthcare IT company Ebit (Esaote Group), to offer DiA’s LVivo...
360 Photos | 360 View Photos | April 12, 2019
This 360 degree view shows staff at the ...
DiA Imaging Analysis Introduces LVivo SAX Ultrasound Analysis Tool
Technology | Cardiovascular Ultrasound | April 09, 2019
DiA Imaging Analysis announced the launch of LVivo SAX, a cardiac analysis tool that helps clinicians quickly and...
Bay Labs Announces New Data on EchoGPS, AutoEF AI Software at ACC.19
News | Cardiovascular Ultrasound | March 15, 2019
Artificial intelligence (AI) company Bay Labs announced the presentation of two studies assessing performance of the...
Canon Medical Systems introduces 33 MHz Ultra-High Frequency Ultrasound Transducer
News | Ultrasound Imaging | March 01, 2019
March 1, 2019 — Expanding its advanced, high-performing Aplio i-series...
Philips Launches Latest Iteration of IntelliSpace Cardiovascular at HIMSS 2019
Technology | Cardiac PACS | February 13, 2019
Philips announced the launch of IntelliSpace Cardiovascular 4.1, its next-generation cardiovascular image and...
An example of Philips' TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal.

An example of Philips' TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. 

Feature | Ultrasound Imaging | February 07, 2019 | Dave Fornell, Editor
Here is a list of six key trends in ul...
ASE Releases Guidelines for Transesophageal Echo in Congenital Heart Disease
News | Ultrasound Transesophageal echo (TEE) | February 05, 2019
February 5, 2019 – The American Society of Echocardiography (ASE) released a new document that provides a comprehensi